Our Organisation

Peter - City Background.jpg (1)

Peter Ellingworth

Chief Executive

Biography

Peter is Chief Executive of the Association of British HealthTech Industries (ABHI), the UK’s leading HealthTech Trade Association, with 400 members operating across medical devices, diagnostics and digital health. Representing the needs of industry at a senior national level with government and the NHS, ABHI ensures businesses are able to grow and provide patients with effective technologies.

Peter sits on the Secretary of State led Life Sciences Council, the sector specific Health Technology Partnership which supports it, and a number of the expert groups that feed into the delivery of the Life Sciences Vision. He is on the Advisory Group and a workstream Chair for the Innovation System Programme that Roland Sinker is overseeing on behalf of NHS England.

A Board member of the Office for Strategic Coordination of Health Research, the Accelerated Access Collaborative and Health Innovation Oxford & Thames Valley, Peter previously chaired the Health Economy work stream of the London Health Commission that was established by the Mayor of London and Lord Ara Darzi. He also advises the Department of Health and Social Care's MedTech Strategy Programme Board.

An experienced supporter of global trade, he was appointed by the Department for Business and Trade as an advisor for its Healthcare UK programme and Free Trade Agreement work, and he has overseen the growth of ABHI’s US Accelerator since its 2017 inception. Through ABHI’s membership of the Global Medical Technology Alliance, and strong bilateral relationships with key global Trade Associations, including AdvaMed and MedTech Europe, Peter leads collaboration with international peers to advocate for industry-critical policies, including compliance, sustainability, data and digital.

In recognition of the close link between the HealthTech industry and that of the regulatory discipline, Peter was appointed to The Organisation for Professionals in Regulatory Affairs (TOPRA)’s Board Nominations Committee in 2022. In the same year, he joined the Life Sciences Council’s Regulatory Reform Advisory Group to work on critical regulatory matters.

Peter has 40 years’ experience in sales, marketing and general management in the UK and across Europe and holds non-executive roles with early stage HealthTech companies. He is committed to supporting ABHI's work on important issues such as equality, diversity and inclusion, and health equity, so that the industry is representative of the people it serves.